跳至主要内容
临床试验/EUCTR2005-004468-22-DE
EUCTR2005-004468-22-DE进行中(未招募)不适用

HEAD-TO-HEAD evaluation of the antiepileptic drugs Levetiracetam (LEV) vs. Sulthiame (STM) in a German multi-centre, doubleblind controlled trial in children with benign epilepsy with centro-temporal spikes - HEAD-STUDIE

Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital0 个研究点目标入组 120 人开始时间: 2006年8月23日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age between 5 and 14 years
  • Weight between 15 kg and 60 kg
  • At least two preceeding seizures within the last 6 months before study start
  • Typical eeg with Rolando focus (centro-temporal spike/sharp-wave-focus)
  • Diagnosis of BECTS G 40.08
  • Written informed consent of parents and child
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Other forms of epilepsy (eg CSWS, Landau-Kleffner-syndrome)
  • Preceeding treatment with antiepileptic drugs
  • Mental Retardation (IQ < 85)
  • Focal neurological deficit
  • Relevant major internistic disease (eg hepatopathy, nephropathy, endocrinopathy. metabolic disorder, cardiovascular disease)
  • Participation in another clinical trial within the last 30 days

研究者

发起方
Klinikum der Universität München, Kinderklinik und Poliklinik im Dr. von Haunerschen Kinderspital

相似试验